India’s healthcare sector continues to attract strong investor interest, with total deal values crossing ₹10,000 crore in Q2 FY26, according to an EY-Parthenon report. The surge was led primarily by hospital chains and diagnostic service providers, highlighting growing confidence in the country’s long-term healthcare demand and expansion potential.

This milestone reflects not only rising capital inflows but also a clear trend of consolidation, capacity expansion, and strategic investments across healthcare sub-segments.

Strong Deal Momentum in Q2 FY26

During the July–September 2025 quarter (Q2 FY26), India witnessed one of its most active periods for healthcare mergers and acquisitions in recent years. The cumulative deal value exceeded ₹10,000 crore, driven by a combination of:

Large hospital acquisitions

Private equity investments

Strategic stake purchases

Select cross-border transactions

Both domestic and global investors actively participated, underlining healthcare’s position as a defensive yet high-growth sector.

Hospitals Lead the Expansion Wave

Hospital operators emerged as the largest contributors to deal value during the quarter. Multi-specialty and specialty hospital chains focused on expanding their footprint through acquisitions rather than slow organic growth.

Key trends in the hospital segment include:

Aggressive bed capacity addition, especially in metro and Tier-2 cities

Rising demand for complex and high-acuity procedures such as oncology, cardiology, and orthopaedics

Improved occupancy rates and revenue per occupied bed

Large healthcare networks are increasingly targeting regional hospitals to build scalable platforms and strengthen referral networks.

Diagnostics: A High-Margin Growth Story

The diagnostics segment also played a crucial role in driving deal activity. Diagnostic chains remain attractive due to their asset-light models, stable cash flows, and strong margins.

Growth drivers for diagnostics include:

Increased focus on preventive healthcare and wellness testing

Rising penetration of advanced tests such as molecular and genetic diagnostics

Expansion into Tier-3 and Tier-4 cities via hub-and-spoke and franchise models

Investors view diagnostics as a scalable business with relatively lower regulatory and operational risk compared to hospitals.

Private Equity and Strategic Investors in Focus

Private equity funds and strategic investors dominated deal participation in Q2 FY26. Their interest was concentrated on businesses with:

Clear profitability visibility

Strong clinical outcomes and brand presence

Technology-enabled service delivery

Opportunities for regional or national expansion

Premium valuations were observed for high-quality assets, reflecting expectations of sustained growth over the medium to long term.

What Is Driving Investor Confidence?

Several structural factors continue to support healthcare deal activity in India:

Rising healthcare consumption due to urbanisation and lifestyle diseases

Improved health insurance penetration

Growing affordability and awareness among patients

Government focus on healthcare infrastructure and digital health initiatives

These factors make healthcare one of the most resilient sectors, even during periods of economic uncertainty.

Outlook for FY26 and Beyond

According to industry experts, the momentum seen in Q2 FY26 is expected to continue through the remainder of the fiscal year. While new hospital projects may initially face margin pressure, long-term fundamentals remain strong.

Key expectations going forward:

Continued consolidation in hospitals and diagnostics

Increased interest in specialty care platforms

Stable deal flow supported by strong investor appetite

India’s healthcare sector is steadily transforming into a large, organised, and investment-friendly market.